BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22187340)

  • 1. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.
    Mikulska M; Del Bono V; Bruzzi P; Raiola AM; Gualandi F; Van Lint MT; Bacigalupo A; Viscoli C
    Infection; 2012 Jun; 40(3):271-8. PubMed ID: 22187340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
    Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
    Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
    Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000.
    Ortega M; Rovira M; Almela M; Marco F; de la Bellacasa JP; Martínez JA; Carreras E; Mensa J
    Ann Hematol; 2005 Jan; 84(1):40-6. PubMed ID: 15480665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
    Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
    Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion.
    Cappellano P; Viscoli C; Bruzzi P; Van Lint MT; Pereira CA; Bacigalupo A
    New Microbiol; 2007 Apr; 30(2):89-99. PubMed ID: 17619251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
    Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
    Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
    Puerta-Alcalde P; Chumbita M; Charry P; Castaño-Díez S; Cardozo C; Moreno-García E; Marco F; Suárez-Lledó M; Garcia-Pouton N; Morata L; Fernández-Avilés F; Martínez-Roca A; Rodríguez G; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
    Transplant Cell Ther; 2021 Jun; 27(6):501.e1-501.e6. PubMed ID: 33891882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
    Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
    Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality.
    Rojas L; Muñoz P; Kestler M; Arroyo D; Guembe M; Rodríguez-Créixems M; Verde E; Bouza E
    J Hosp Infect; 2013 Nov; 85(3):196-205. PubMed ID: 24001997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, Etiology, Risk Factors, and Outcomes of Bloodstream Infection after a Second Hematopoietic Stem Cell Transplantation.
    Ohta T; Ueno T; Uehara Y; Yokoyama T; Nakazawa M; Sato Y; Uchida Y; Ohno Y; Sugio Y
    Intern Med; 2023 Nov; 62(22):3305-3316. PubMed ID: 37032079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.
    Dandoy CE; Kim S; Chen M; Ahn KW; Ardura MI; Brown V; Chhabra S; Diaz MA; Dvorak C; Farhadfar N; Flagg A; Ganguly S; Hale GA; Hashmi SK; Hematti P; Martino R; Nishihori T; Nusrat R; Olsson RF; Rotz SJ; Sung AD; Perales MA; Lindemans CA; Komanduri KV; Riches ML
    JAMA Netw Open; 2020 Jan; 3(1):e1918668. PubMed ID: 31913492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.
    Yan CH; Wang Y; Mo XD; Sun YQ; Wang FR; Fu HX; Chen Y; Han TT; Kong J; Cheng YF; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S162-S173. PubMed ID: 30423054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).
    Weisser M; Theilacker C; Tschudin Sutter S; Babikir R; Bertz H; Götting T; Dettenkofer M; Kern WV; Widmer AF;
    Clin Microbiol Infect; 2017 Nov; 23(11):854-859. PubMed ID: 28366613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
    Gjaerde LI; Moser C; Sengeløv H
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
    Wang L; Wang Y; Fan X; Tang W; Hu J
    Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough bloodstream infections in critically ill non-neutropenic patients: higher incidence and better survival than non-breakthrough infections.
    Papadimitriou-Olivgeris M; Kolonitsiou F; Solomou A; Karamouzos V; Anastassiou ED; Christofidou M; Spiliopoulou I; Fligou F; Marangos M
    J Med Microbiol; 2019 Oct; 68(10):1544-1551. PubMed ID: 31436523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.